Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study
Background:
Pancreatic cancer is the fourth-leading cause of cancer death in both men and women in the United States. The currently identified common susceptibility loci account for a small fraction of estimated heritability. We sought to estimate overall heritability of pancreatic cancer and partition the heritability by variant frequencies and functional annotations.
Methods:
Analysis using the genome-based restricted maximum likelihood method (GREML) was conducted on Pancreatic Cancer Case-Control Consortium (PanC4) genome-wide association study (GWAS) data from 3,568 pancreatic cancer cases and 3,363 controls of European Ancestry.
Results:
Applying linkage disequilibrium- and minor allele frequency-stratified GREML (GREML-LDMS) method to imputed GWAS data, we estimated the overall heritability of pancreatic cancer to be 21.2% (SE = 4.8%). Across the functional groups (intronic, intergenic, coding, and regulatory variants), intronic variants account for most of the estimated heritability (12.4%). Previously identified GWAS loci explained 4.1% of the total phenotypic variation of pancreatic cancer. Mutations in hereditary pancreatic cancer susceptibility genes are present in 4% to 10% of patients with pancreatic cancer, yet our GREML-LDMS results suggested these regions explain only 0.4% of total phenotypic variance for pancreatic cancer.
Conclusions:
Although higher than previous studies, our estimated 21.2% overall heritability may still be downwardly biased due to the inherent limitation that the contribution of rare variants in genes with a substantive overall impact on disease are not captured when applying these commonly used methods to imputed GWAS data.
Impact:
Our work demonstrated the importance of rare and common variants in pancreatic cancer risk.
Top-30
Journals
|
1
2
3
|
|
|
Cancers
3 publications, 5.17%
|
|
|
Cancer Epidemiology Biomarkers and Prevention
3 publications, 5.17%
|
|
|
Metabolites
2 publications, 3.45%
|
|
|
Frontiers in Oncology
2 publications, 3.45%
|
|
|
Cancer Research
2 publications, 3.45%
|
|
|
Hepatology
2 publications, 3.45%
|
|
|
Current Opinion in Gastroenterology
1 publication, 1.72%
|
|
|
American Journal of Gastroenterology
1 publication, 1.72%
|
|
|
International Journal of Environmental Research and Public Health
1 publication, 1.72%
|
|
|
Cancer and Metastasis Reviews
1 publication, 1.72%
|
|
|
Genome Medicine
1 publication, 1.72%
|
|
|
Nature Reviews Gastroenterology and Hepatology
1 publication, 1.72%
|
|
|
InFo Hämatologie + Onkologie
1 publication, 1.72%
|
|
|
Hereditary Cancer in Clinical Practice
1 publication, 1.72%
|
|
|
Onkologe
1 publication, 1.72%
|
|
|
Modern Pathology
1 publication, 1.72%
|
|
|
Journal of Gastroenterology
1 publication, 1.72%
|
|
|
Gastrointestinal Endoscopy Clinics of North America
1 publication, 1.72%
|
|
|
Seminars in Cancer Biology
1 publication, 1.72%
|
|
|
Cancer Treatment Reviews
1 publication, 1.72%
|
|
|
Hematology/Oncology Clinics of North America
1 publication, 1.72%
|
|
|
Biochimica et Biophysica Acta - Reviews on Cancer
1 publication, 1.72%
|
|
|
The Lancet Gastroenterology and Hepatology
1 publication, 1.72%
|
|
|
EBioMedicine
1 publication, 1.72%
|
|
|
Journal of Biomedical Informatics
1 publication, 1.72%
|
|
|
Seminars in Oncology
1 publication, 1.72%
|
|
|
Pancreatology
1 publication, 1.72%
|
|
|
American Journal of Clinical Nutrition
1 publication, 1.72%
|
|
|
Journal of Medical Genetics
1 publication, 1.72%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 25.86%
|
|
|
Springer Nature
11 publications, 18.97%
|
|
|
MDPI
7 publications, 12.07%
|
|
|
American Association for Cancer Research (AACR)
5 publications, 8.62%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
4 publications, 6.9%
|
|
|
Wiley
4 publications, 6.9%
|
|
|
Frontiers Media S.A.
2 publications, 3.45%
|
|
|
Oxford University Press
2 publications, 3.45%
|
|
|
American Society for Nutrition
1 publication, 1.72%
|
|
|
BMJ
1 publication, 1.72%
|
|
|
American Diabetes Association
1 publication, 1.72%
|
|
|
Taylor & Francis
1 publication, 1.72%
|
|
|
Tomsk Cancer Research Institute
1 publication, 1.72%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.72%
|
|
|
Moffitt Cancer Center
1 publication, 1.72%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.